Oxybutynin Chloride Tablet
Product Images NDC 70518-2640

10 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 70518-2640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Oxybutynin Chloride 5mg 70518 2640 00

Oxybutynin Chloride 5mg 70518 2640 00
Oxybutynin Chloride 5 mg tablet label from RemedyRepack Inc. The label indicates a quantity of 30 tablets, includes NDC 70518-2640-00, and advises storage conditions at 20-25°C with permitted excursions. It also notes repackaging by RemedyRepack Inc. in Indiana, with a QR code and manufacturer information for KVK-Tech, Newtown, PA.*
FDA Label Image

Mm2 (Oxybutynin Chloride 5mg 70518 2640 01)

Mm2 (Oxybutynin Chloride 5mg 70518 2640 01)
Oxybutynin Chloride 5 mg tablet label showing a quantity of 60 tablets. The label includes the product name, strength, dosage form, and repackager RemedyRepack Inc., located in Indiana, PA, with a note to see the package insert for directions. The label also lists manufacturer KVK-Tech in Newtown, PA, and includes storage instructions and a QR code.*
FDA Label Image

Oxybutynin Chloride 5mg 70518 2640 02

Oxybutynin Chloride 5mg 70518 2640 02
Oxybutynin Chloride 5 mg oral tablets, quantity 90, labeled as Rx only. The label shows the NDC number 70518-2640-02, and indicates the product is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions specify 20-25°C with permitted excursions. The manufacturer is listed as KVK-Tech, Newtown, PA.*
FDA Label Image

Oxybutynin Chloride 5mg 70518 2640 03

Oxybutynin Chloride 5mg 70518 2640 03
Oxybutynin Chloride 5 mg tablet packaging label showing quantity of 180 tablets. The label includes NDC 70518-2640-03 and repackaging information by RemedyRepac Inc. Directions reference the package insert. Manufacturer is KVK-Tech, Newtown, PA. Storage instructions are to keep at 20-25°C with permitted excursions.*
FDA Label Image

Structural Formula (Figure 1 Structure)

Structural Formula (Figure 1 Structure)
Chemical structure of oxybutynin chloride, showing its molecular components including a cyclohexyl ring, phenyl group, ester linkage, and a tertiary amine with ethyl groups, presented with its hydrochloride salt form.*
FDA Label Image

Table 1 (Figure 2 Table1)

Table 1 (Figure 2 Table1)
A data table presenting pharmacokinetic parameters for R-Oxybutynin and S-Oxybutynin, including maximum concentration (Cmax), time to maximum concentration (Tmax), area under the curve to the last measurable concentration (AUClast), and area under the curve to infinity (AUCinf), with values in ng/mL or hours and standard deviations in parentheses.*
FDA Label Image

Figure 1 (Figure 3 Figure1)

Figure 1 (Figure 3 Figure1)
A line graph depicting mean plasma R-oxybutynin concentration (ng/mL) over 24 hours after administration of Oxybutynin 5 mg taken three times daily (TID). The x-axis represents time in hours, and the y-axis represents concentration levels. Data points with error bars show fluctuations in plasma concentration through the dosing interval.*
FDA Label Image

Table 2 (Figure 4 Table2)

Table 2 (Figure 4 Table2)
A data table presenting pharmacokinetic parameters including Cmax, Tmax, and AUC for four metabolites: R-Oxybutynin, S-Oxybutynin, R-Desethyloxybutynin, and S-Desethyloxybutynin. Values include means with standard deviations and notes indicating pooled data and end of the dosing interval details.*
FDA Label Image

Figure 2 (Figure 5 Figure2)

Figure 2 (Figure 5 Figure2)
A line graph showing the mean plasma concentration of R-Oxybutynin over time. The x-axis represents time in hours (0 to 12), and the y-axis represents mean plasma concentration in ng/mL, ranging from 0 to 10. Data points at various time intervals include error bars depicting variability.*
FDA Label Image

Table 3 (Figure 6 Table3)

Table 3 (Figure 6 Table3)
A data table listing adverse events associated with Oxybutynin Chloride (5-20 mg/day) in 199 subjects. The table categorizes adverse events by body system, including infections, psychiatric disorders, nervous system disorders, eye disorders, gastrointestinal disorders, and renal and urinary disorders, with corresponding percentages for each adverse event.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.